Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database

PURPOSE: The aim was to understand real-world cyclin-dependent kinase (CDK) 4 and 6 inhibitor use in Japan. METHODS: This retrospective observational study used a Japanese administrative claims database and included patients with presumptive hormone receptor-positive, human epidermal growth factor r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Masaaki, Takada, Masahiro, Nakayama, Takahiro, Masuda, Norikazu, Shiheido, Hirokazu, Cai, Zhihong, Huang, Yu-Jing, Kawaguchi, Tsutomu, Tanizawa, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823084/
https://www.ncbi.nlm.nih.gov/pubmed/36414795
http://dx.doi.org/10.1007/s10549-022-06816-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823084/
https://www.ncbi.nlm.nih.gov/pubmed/36414795
http://dx.doi.org/10.1007/s10549-022-06816-9

Ejemplares similares